大数跨境
0
0

演讲嘉宾介绍|奥博资本合伙人徐荻勇先生

演讲嘉宾介绍|奥博资本合伙人徐荻勇先生 雅法全球生命科学
2025-11-24
36
导读:2026 年 1 月 11 日(旧金山洲际酒店)——我们很高兴地宣布, 奥博资本将受邀在ACCESS ASIA

2026 年 1 月 11 日(旧金山洲际酒店)——我们很高兴地宣布, 奥博资本将受邀在ACCESS ASIA 雅法药通亚洲 BD 论坛 @ JPM 2026 上发表演讲。
January 11, 2026 (InterContinental San Francisco) — We're pleased to announce that OrbiMed will speak at YAFO ACCESS ASIA BD Forum @ JPM 2026.   
由雅法主办的"ACCESS ASIA"论坛,延续ACCESS CHINA的成功经验,将亚洲领先的生物科技跨境平台拓展至更广阔领域,连接创新者与全球药企、投资机构和战略合作伙伴。论坛将于2026年1月11日在旧金山洲际酒店举行,为亚洲生物科技企业提供全球舞台,展示创新成果,促成战略合作,开拓商业发展新机遇。更多信息请访问:https://biotochina.org/
ACCESS ASIA, hosted by YAFO, builds on the success of ACCESS CHINA, expanding Asia's leading cross-border biotech platform to connect innovators with global pharma, investors, and strategic partners.

Taking place on January 11, 2026, at the InterContinental San Francisco, the forum provides a global stage for Asian biotech companies to showcase their innovation, foster partnerships, and explore new business development opportunities.
View more information at:https://biotochina.org/
演讲嘉宾
About the speaker

徐荻勇先生 Diyong Xu
奥博资本合伙人
Partner at OrbiMed

现任 OrbiMed 纽约办公室合伙人,主要专注于生物技术、医疗器械和诊断领域的风险投资。在加入 OrbiMed 之前,他曾在 Lazard 的医疗健康组担任投资银行分析师,从事并购、融资及战略顾问项目。徐荻勇拥有斯坦福大学管理科学与工程硕士学位,以及达特茅斯学院分子与细胞生物学硕士学位。他在浙江大学获得生物科学本科学位。

Diyong Xu is a Partner at OrbiMed in New York, where he focuses on venture capital investments in biotech, medtech, and diagnostics companies. Prior to joining OrbiMed, Diyong worked as an investment banker in the healthcare group at Lazard, concentrating on M&A, financings, and strategic advisory projects. Diyong holds an M.S. in Management Science and Engineering from Stanford University and an M.S. in Molecular and Cellular Biology from Dartmouth College. He earned his B.S. in Biology from Zhejiang University in China.

关于ACCESS ASIA 药通亚洲 BD Forum @ JPM 2026
About ACCESS ASIA BD Forum @ JPM 2026
2026 年 1 月 11 日, ACCESS ASIA 药通亚洲BD论坛 @ JPM 2026 将在美国旧金山洲际酒店正式举行。
ACCESS ASIA BD Forum @ JPM is scheduled to be held on January 11, 2026, at the InterContinental San Francisco, alongside the J.P. Morgan Healthcare Conference Week.
本次为期一天的论坛将呈现主题演讲、圆桌讨论、企业路演、公司展示,以及 1 对 1 合作洽谈,旨在连接亚洲领先的生物科技创新者与全球制药公司、投资机构及战略合作伙伴。
This full-day forum will feature keynote speeches, panel discussions, corporate presentations, company showcases, and 1-on-1 partnering meetings connecting Asia's leading biotech innovators with global pharma, investors, and strategic partners.
会议名称: ACCESS ASIA 药通亚洲 BD 论坛 @ JPM 2026
时间 & 地点: 2026 年 1 月 11 日 | 旧金山洲际酒店
更多活动详情请至:  https://biotochina.org/
Conference Name: ACCESS ASIA BD Forum @ JPM 2026
Date & Venue: January 11, 2026 | InterContinental San Francisco
View more information at: https://biotochina.org/
参会注册
如需报名参加 ACCESS ASIA 药通亚洲 BD 论坛 @ JPM
To register as attendee for ACCESS ASIA BD Forum @, please visit or sacn the QR code:
https://jsj.top/f/AqkB9m?x_field_1=wechat
图片
联系方式
相文迪 (Wendi Xiang)
Wxiang@yafocapital.com

【声明】内容源于网络
0
0
雅法全球生命科学
1234
内容 489
粉丝 0
雅法全球生命科学 1234
总阅读989
粉丝0
内容489